PMID- 22979950 OWN - NLM STAT- MEDLINE DCOM- 20130226 LR - 20211021 IS - 1743-422X (Electronic) IS - 1743-422X (Linking) VI - 9 DP - 2012 Sep 14 TI - Identification of B cell epitopes reactive to human papillomavirus type-16L1- derived peptides. PG - 199 LID - 10.1186/1743-422X-9-199 [doi] AB - BACKGROUND: Persistent infection of human papillomavirus (HPV) types 16 and 18 causes cervical cancer. To better understand immune responses to the prophylactic vaccine, HPV 16/18 L1 virus-like particles (HPV-VLPs), we investigated B cell epitopes of HPV16 L1-derived peptides. METHODS: Sera from mice immunized with HPV-16/18 L1 VLPs were analyzed for their IgG titers against 10 different HPV16 L1-derived peptides (20-mer) that contain human leukocyte antigen (HLA)-class I A-2, A-24 and class II DR. RESULTS: One 20-mer peptide at positions 300 to 319 was identified as a common B cell epitope in both Balb/c (H-2d) and C57BL/6 (H-2b) mice. Mapping analysis showed that the 10-amino-acid sequence at positions 304 to 313 was an immunogenic portion. It is of note that the binding capability of this 10-mer peptide to the HLA-A2 and HLA-A24 molecules was confirmed by the HLA class I stabilization assay. In addition, one unique 20-mer was determined as a B cell epitope in each strain. CONCLUSIONS: These results might provide new information for better understanding of immune responses to HPV 16 L1. FAU - Fukui, Akimasa AU - Fukui A AD - Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Japan. FAU - Matsueda, Satoko AU - Matsueda S FAU - Kawano, Kouichiro AU - Kawano K FAU - Tsuda, Naotake AU - Tsuda N FAU - Komatsu, Nobukazu AU - Komatsu N FAU - Shichijo, Shigeki AU - Shichijo S FAU - Sasada, Tetsuro AU - Sasada T FAU - Hattori, Satoshi AU - Hattori S FAU - Ushijima, Kimio AU - Ushijima K FAU - Itoh, Kyogo AU - Itoh K FAU - Kamura, Toshiharu AU - Kamura T LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120914 PL - England TA - Virol J JT - Virology journal JID - 101231645 RN - 0 (Antibodies, Viral) RN - 0 (Capsid Proteins) RN - 0 (Epitopes, B-Lymphocyte) RN - 0 (HLA-A Antigens) RN - 0 (Immunoglobulin G) RN - 0 (Oncogene Proteins, Viral) RN - 6LTE2DNX63 (L1 protein, Human papillomavirus type 16) SB - IM MH - Animals MH - Antibodies, Viral/blood MH - Capsid Proteins/*immunology MH - Epitope Mapping MH - Epitopes, B-Lymphocyte/*immunology MH - Female MH - HLA-A Antigens/metabolism MH - Humans MH - Immunoglobulin G/blood MH - Mice MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Oncogene Proteins, Viral/*immunology MH - Protein Binding PMC - PMC3463485 EDAT- 2012/09/18 06:00 MHDA- 2013/02/27 06:00 PMCR- 2012/09/14 CRDT- 2012/09/18 06:00 PHST- 2012/02/22 00:00 [received] PHST- 2012/09/11 00:00 [accepted] PHST- 2012/09/18 06:00 [entrez] PHST- 2012/09/18 06:00 [pubmed] PHST- 2013/02/27 06:00 [medline] PHST- 2012/09/14 00:00 [pmc-release] AID - 1743-422X-9-199 [pii] AID - 10.1186/1743-422X-9-199 [doi] PST - epublish SO - Virol J. 2012 Sep 14;9:199. doi: 10.1186/1743-422X-9-199.